|
ANGEL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.12839999957914E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.640700E-04 |
| Normal-vs-Stage2 |
1.366650E-04 |
| Normal-vs-Stage3 |
2.29409824470395E-11 |
| Normal-vs-Stage4 |
3.895900E-03 |
| Stage1-vs-Stage2 |
1.706820E-01 |
| Stage1-vs-Stage3 |
1.88148999999971E-05 |
| Stage1-vs-Stage4 |
1.817210E-01 |
| Stage2-vs-Stage3 |
1.240160E-01 |
| Stage2-vs-Stage4 |
6.123800E-01 |
| Stage3-vs-Stage4 |
7.737200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.62020000036034E-08 |
| Normal-vs-AfricanAmerican |
9.348500E-02 |
| Normal-vs-Asian |
7.569800E-01 |
| Caucasian-vs-AfricanAmerican |
5.537700E-02 |
| Caucasian-vs-Asian |
9.051600E-02 |
| AfricanAmerican-vs-Asian |
3.460000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6180999999893E-06 |
| Normal-vs-Female |
4.65680000005797E-07 |
| Male-vs-Female |
8.705800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.496300E-03 |
| Normal-vs-Age(41-60Yrs) |
7.568000E-04 |
| Normal-vs-Age(61-80Yrs) |
6.1352000146897E-09 |
| Normal-vs-Age(81-100Yrs) |
7.6916000000038E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.345400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.194800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.999600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.593500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.724100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.204400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.395800E-01 |
| Normal-vs-Grade 2 |
1.969170E-04 |
| Normal-vs-Grade 3 |
9.06430486224963E-11 |
| Normal-vs-Grade 4 |
9.042200E-03 |
| Grade 1-vs-Grade 2 |
1.849630E-02 |
| Grade 1-vs-Grade 3 |
9.79789999999703E-05 |
| Grade 1-vs-Grade 4 |
1.039690E-02 |
| Grade 2-vs-Grade 3 |
2.242800E-03 |
| Grade 2-vs-Grade 4 |
3.344800E-01 |
| Grade 3-vs-Grade 4 |
9.918000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.02649999611515E-08 |
| Normal-vs-ccB subtype |
6.25239999999527E-05 |
| ccA subtype-vs-ccB subtype |
3.661000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.039700E-04 |
| Normal-vs-N1 |
1.82500000001085E-07 |
| N0-vs-N1 |
8.158100E-04 |
|
|
